Cyclosporine-A in severe chronic urticaria: the option for long-term therapy

Allergy
A Kessel, E Toubi

Abstract

The treatment of severe chronic urticaria (CU) remains a difficult goal to achieve. Many patients do not respond to anti-histamine therapy, even when off-label doses are given. Thus, cyclosporine-A (CsA) becomes a good therapeutic option for severe patients and for some, long-term therapy is required. We evaluated the effectiveness and safety of low-dose CsA, when treatment cannot be discontinued and long-term CsA therapy is needed to maintain severe CU in remission. Among 2000 patients with CU who were referred to our outpatient clinic, 120 patients who suffered from a very severe CU began treatment with CsA 3 mg/kg. A clinical and laboratory followup was performed during this period of treatment. In 20 patients, CsA was discontinued within 2-15 days after initiation because of side-effects. Among 62 of the remaining 100 patients (62%), CsA was administered for a period of 3 months with a highly beneficial outcome. In another 20 patients (20%), CsA was considered beneficial; however, it was required for a longer period of time, 5-10 years for some of the cases. In all cases, CsA was well tolerated and most important, it was safe. For 18 patients (18%), CsA therapy was reported as failed. A low dose of CsA is a good option for ...Continue Reading

References

Dec 1, 1991·Journal of the American Academy of Dermatology·M S FradinJ J Voorhees
Feb 1, 1997·The British Journal of Dermatology·B F O'DonnellM W Greaves
Sep 24, 1999·Acta Dermato-venereologica·G TessariC Chieregato
Aug 22, 2000·The British Journal of Dermatology·C E GrattanM W Greaves
Oct 29, 2000·Journal of Clinical Immunology·E ToubiH Hacham
Aug 21, 2001·Journal of the American Academy of Dermatology·M M KozelJ D Bos
Jun 22, 2002·Journal of the American Academy of Dermatology·Daniel Berg, Clark C Otley
Mar 26, 2003·The British Journal of Dermatology·E NettisA Tursi
Jul 9, 2003·The Journal of Allergy and Clinical Immunology·Yoko KikuchiAllen P Kaplan
Feb 24, 2005·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·A KesselE Toubi
Oct 3, 2006·Journal of the American Academy of Dermatology·Gino A VenaUNKNOWN Neo-I-30 Study Group
Jul 27, 2007·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Mine OzkanBahattin Colakoğlu
Apr 8, 2009·The Journal of Allergy and Clinical Immunology·Aharon Kessel, Elias Toubi

❮ Previous
Next ❯

Citations

Aug 21, 2013·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·B WediA Kapp
Mar 25, 2011·Current Allergy and Asthma Reports·Allen P Kaplan
Jul 4, 2013·Current Allergy and Asthma Reports·Jenny M Stitt, Stephen C Dreskin
Oct 3, 2013·American Journal of Clinical Dermatology·Riccardo AseroMassimo Cugno
Nov 14, 2013·Dermatology Research and Practice·Sujoy KhanHarpal Singh
Sep 5, 2014·Immunotherapy·Jenny M Stitt, Stephen C Dreskin
Nov 11, 2014·The World Allergy Organization Journal·Paul A Greenberger
Jun 26, 2012·Current Opinion in Allergy and Clinical Immunology·Timothy D Trojan, David A Khan
Nov 30, 2011·Immunopharmacology and Immunotoxicology·M T VenturaA Arsieni
Feb 18, 2014·Expert Review of Clinical Immunology·Nadine Marrouche, Clive Grattan
Jul 16, 2015·Expert Review of Clinical Immunology·Riccardo AseroAngelo Valerio Marzano
Mar 25, 2014·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Allen P Kaplan
Dec 18, 2013·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Roy Anthony OrdenSarbjit S Saini
Nov 23, 2013·Immunology and Allergy Clinics of North America·Riccardo AseroMassimo Cugno
Feb 26, 2014·The Journal of Allergy and Clinical Immunology. in Practice·David A Khan
May 4, 2013·Immunology and Allergy Clinics of North America·Mario Sánchez-BorgesArnaldo Capriles-Hulett
May 1, 2012·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Ravi K ViswanathanSameer K Mathur
Nov 30, 2011·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Seth M HollanderH James Wedner
Jul 26, 2011·Journal of the American Academy of Dermatology·Andrew B ZimmermanNicholas A Soter
Sep 17, 2013·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Marcus MaurerTorsten Zuberbier
Feb 5, 2013·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Carmi Geller-Bernstein, Amos Etzioni
Dec 14, 2011·Journal of the European Academy of Dermatology and Venereology : JEADV·K WellerM Maurer
Jul 22, 2015·Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology·Sinisa SavicClive Grattan
Jul 23, 2011·Allergology International : Official Journal of the Japanese Society of Allergology·Sayuri TodaMichihiro Hide
Jun 11, 2016·Journal of the European Academy of Dermatology and Venereology : JEADV·P StaubachG Sussman
Jan 4, 2012·Annales de dermatologie et de vénéréologie·A Dupuy
Oct 18, 2016·The Journal of Allergy and Clinical Immunology. in Practice·Sharon Seth, David A Khan
Feb 13, 2015·Anais Brasileiros De Dermatologia·Paulo Ricardo CriadoVitor Manoel Silva dos Reis
May 18, 2017·The Journal of Dermatological Treatment·Jesper Grønlund HolmSimon Francis Thomsen
Jun 12, 2018·JAAPA : Official Journal of the American Academy of Physician Assistants·Lindsay WebsterMark E Archambault
Sep 16, 2017·Allergy, Asthma & Immunology Research·Allen P Kaplan
Jun 28, 2019·Current Opinion in Allergy and Clinical Immunology·Allen P Kaplan
Mar 1, 2020·The Journal of Allergy and Clinical Immunology. in Practice·Jorge SánchezRicardo Cardona
Jan 4, 2013·The World Allergy Organization Journal·Mario Sánchez-BorgesUNKNOWN WAO Scientific and Clinical Issues Council
Feb 5, 2021·Allergy·Jie Shen FokMarcus Maurer
Mar 7, 2021·Actas dermo-sifiliográficas·B Pinilla MartínF J Ortiz de Frutos
Nov 3, 2020·ImmunoTargets and Therapy·Elias Toubi, Zahava Vadasz
Jun 19, 2021·The World Allergy Organization Journal·Mario Sánchez-BorgesJose Antonio Ortega Martell

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.